APA (7th ed.) Citation

WM, S. A., A, S., AE, A. A., RM, E. S., MM, A., RS, T., . . . DA, M. (2023). Effect of dapagliflozin against NAFLD and dyslipidemia in type 2 diabetic albino rats: Possible underlying mechanisms. European review for medical and pharmacological sciences, 27(17), 8101. https://doi.org/10.26355/eurrev_202309_33570

Chicago Style (17th ed.) Citation

WM, Said Ahmed, et al. "Effect of Dapagliflozin Against NAFLD and Dyslipidemia in Type 2 Diabetic Albino Rats: Possible Underlying Mechanisms." European Review for Medical and Pharmacological Sciences 27, no. 17 (2023): 8101. https://doi.org/10.26355/eurrev_202309_33570.

MLA (9th ed.) Citation

WM, Said Ahmed, et al. "Effect of Dapagliflozin Against NAFLD and Dyslipidemia in Type 2 Diabetic Albino Rats: Possible Underlying Mechanisms." European Review for Medical and Pharmacological Sciences, vol. 27, no. 17, 2023, p. 8101, https://doi.org/10.26355/eurrev_202309_33570.